Meet the Qurgen Team
Qurgen gathers the world's top professional talents in iPS stem cells and regenerative medical research field, and is committed to establish stem cells technology platform and R&D and clinical translation based on the protein induced in-situ cell reprogramming technology.
Our Team
Prof. Jianjun Wang
Founder, Chairman, Chief Scientist, Acting CEO
- Professor, Wayne State University, School of Medicine
- Main Inventor, Qurgen Technology Platforms
- Holds more than 50 international patents
- Published 78 peer-reviewed SCI publications
- Experts in protein delivery, stem cell therapies and regenerative medicine
Prof. Qianqian Li, MD
Co-Founder, Director, Chief Technology Officer (CTO)
- Associate Professor, Wayne State University, School of Medicine
- Main inventor, Qurgen Technology Platforms
- Expert in protein delivery and stem cell therapies for major diseases
- Published 47 peer-review SCI publications
- Holds more than 50 international patents
Prof. Feng Jiang
Co-Founder, Director, Chief Operating Officer (COO)
- Senior investigator of Henry Ford Hospital
- 30+ years of experience in cancer therapeutic development
- Co-inventor, Qurgen Technology Platform,
- Published 48 SCI publications
Dr. Yan Chai
Senior VP, Business Development & Secretary, BOD
- Doctor of Business Administration in Finance, Arizona State Univ.
- Analyst, McKinsey & Company.
- Key member of Harvard Management Company’s China Fund.
- Principal, IQVIA, Consulting, Contracted Commercial Service, Public policy & Government Relations.
Dr. Daniel C. Yang, MD, PhD
Chief Medical Officer (CMO)
- MD/PhD in Medical Oncology, Heidelbery University (Germany)
- USMLE (ECFMG) Certificate
- 30+ years experience in > 200 global clinical trials
- Expertise in Medical Monitoring, Medical Safety and pharmacovigilance
- CEO, G2 Biopharma, Princeton, US
Dr. Zhi Zeng, MD, PhD
Vice President, Longevity Health and Regenerative Medicine
- 24 year of US licensed physician practitioner in Internal Medicine
- American licensed physician practitioner in Cosmetic Medicine
- Co-inventor, Qurgen Technology Platform,
- Published 48 SCI publications
Dr. Ming Guo
Co-Founder, Director, Senior VP
- 20+ years of management and operation experience
- Strategic investor in biopharma
- Founder of ATA (Beijing) which is listed in NASDQ
- Founder of MaxMin Computer
Dr. Steven Kalkanis, MD
Chair, Medical Advisory Committee
- CEO, Henry Ford Medical Group;
- Chief Academic Officer, Henry Ford Health System;
- Medical Director, Henry Ford Cancer Institute;
- President, Congress of Neurological Surgeons;
- Director, American Board of Neurological Surgery.
Prof. Michael Chopp
Co-Founder, Chief Technical Advisor
- Director of Neuroscience Institute, Henry Ford Hospital;
- World-renowned scientist in neuroscience, cancer and stem cell;
- Published > 600 SCI papers
- Advisor for 40+ famous US and European pharmaceutical companies.
Prof. Ji Jiang, MD, PhD
Chief Clinical Pharmacology Advisor
- Professor of Nuclear Medicine, Peking Union Medical College Hospital
- Member, Professional Committee of Pharmacology Society
- Published more than 30 peer-reviewed publications.
- Experts in clinical pharmacokinetics, pharmacodynamics and pharmacology